A Smart + Strong Site
Subscribe to:
E-newsletters
POZ magazine
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Treatment News » Top Stories

Most Popular Stories
Marijuana and its CD4 Receptors: A New HIV Treatment Strategy?
Pathway to a Cure: Cancer Drug Helps Purge HIV From Resting Cells
Life Expectancy With HIV Increases Dramatically
Undetectable Viral Load? Not Necessarily in Semen
Engineering CD8 Cells to Kill HIV in Tissues
Pathway to a Cure: Positive Results Continue for Sangamo's CCR5 Gene Therapy
Revised U.S. Guidelines: HIV Treatment is Recommended for All People Living With HIV
What's That Mean?
(just double-click it!)

If you don't understand one of the words in this article, just double-click it. A window will open with a definition from mondofacto's On-line Medical Dictionary. If the double-click feature doesn't work in your browser, you can enter the word below:

Most Popular Lessons
Aging & HIV
The HIV Life Cycle
Shingles
Herpes Simplex Virus
Syphilis & Neurosyphilis
Treatments for Opportunistic Infections (OIs)
What is AIDS & HIV?
More News

Have medical or treatment news about HIV? Send press releases, news tips and other announcements to editors@aidsmeds.com.

Click here for more news


emailprint

February 24, 2009

Being Female Linked to Poorer Survival

HIV-positive women have a higher likelihood of premature death from any cause compared with HIV-positive men, according to a study published online February 16 in The Journal of Infectious Diseases. A person’s race or history of substance use was not associated with an increased risk of death.

Early in the epidemic, studies suggested that an HIV-positive person’s sex and race influences survival, with both female and black patients having higher rates of death at younger ages than male or white patients. Later studies, which controlled for such factors as access to experienced health care providers and the best HIV treatment, appeared to diminish those differences in survival.

To determine the influence of race and sex on survival in the modern treatment era, Diana Lemly, MD, from the Vanderbilt University School of Medicine in Nashville and her colleagues examined the medical records of 2,605 HIV-positive patients from the university’s Comprehensive Care Center. Patients were treated between 1998 and 2005. Twenty-four percent of the patients were female, and 38 percent were black.

In general, black patients tended to present for care with lower CD4 cell counts and were less likely than white patients to have been on antiretroviral (ARV) therapy before being seen at the clinic. Female patients tended to be younger than male patients and to enter care with higher CD4 counts. The average follow-up was just over two years. A total of 253 deaths occurred during the study period.

After controlling for the total amount of time that a person spent taking ARV therapy, researchers found that women, older patients and people with low CD4 counts before starting ARV treatment all had a higher risk of death than men, younger patients and people who started treatment with higher CD4 counts. Black patients also had a higher death rate than white patients, but this was due to their being less likely to start ARV therapy and stay on therapy.

Lemly and her colleagues speculate that the higher risk of premature death in women may be due to factors such as poorer adherence, higher rates of depression and lack of social support rather than biological differences.

Search: Women, female, black, race, survival, Diana Lemly, Vanderbilt University


Scroll down to comment on this story.

Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The AIDSmeds team review all comments before they are posted. Please do not include ":" "@" "<" ">" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

| Posting Rules

Previous Comments:

       


[Go to top]

Quick Links
AIDSmeds en Español
About HIV and AIDS
Lab Tests
Clinical Trials
HIV Meds
Starting Treatment
Switching Treatment
Drug Resistance
Side Effects
Disclosure
Lipodystrophy
Hepatitis & HIV
Women & Children
Fact Sheets
Treatment News
Community Forums
Blogs
Conference Coverage
Health Services Directory
POZ Magazine


    AnnaMarie528
    Austin
    Texas


    newlife202
    JOLIET
    Illinois


    MascVersWPB
    Lake Worth
    Florida


    ZanderPetros
    San Jose
    California
Click here to join POZ Personals!
Conference Coverage

19th Conference on Retroviruses and Opportunistic Infections (CROI 2012)
Seattle, Washington
March 5 - 8, 2012


6th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2011)
Rome, Italy
July 17 - 20, 2011


18th Conference on Retroviruses and Opportunistic Infections (CROI 2011)
Boston, MA
February 27 - March 2, 2011


more conference coverage

[ about AIDSmeds | AIDSmeds advisory board | our staff | advertising policy | advertise/contact us]
© 2012 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.